Get the latest Science News and Discoveries

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s


None

Get the Android app

Or read this on New York Times

Read more on:

Photo of Eli Lilly’s

Eli Lilly’s

Photo of donanemab

donanemab

Photo of new drug

new drug

Related news:

News photo

New Drug Approved for Early Alzheimer’s

News photo

The FDA Approved Menthol Vapes Despite Serious Risks. Here's Why.

News photo

FDA: Severe Illness From Psychedelic Candy Now Seen in 20 States